# Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries

> **NCT00859196** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 15 (actual)

## Conditions studied

- Wound Healing
- Cell Proliferation
- Gene Expression

## Interventions

- **DRUG:** Dexpanthenol (BAY81-2996)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00859196
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-02
- **Final completion:** 2009-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00859196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00859196, "Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00859196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
